Literature DB >> 25266673

Predictors of Candida spp. as causative agents of catheter-related bloodstream infections.

Miki Nagao1, Gou Hotta2, Masaki Yamamoto2, Yasufumi Matsumura2, Yutaka Ito3, Shunji Takakura2, Satoshi Ichiyama2.   

Abstract

We conducted this study to identify risk factors that may predict whether Candida spp. are causative agents of suspected catheter-related bloodstream infections (CRBSIs). All patients with laboratory-confirmed CRBSIs at Kyoto University Hospital between 2009 and 2011 were included. We compared the clinical features of candidal CRBSIs (78 cases) and non-candidal CRBSIs (258 cases). According to a multivariate analysis, a solid tumor (odds ratio [OR], 3.11; 95% confidence interval [CI], 1.75-5.53), total parental nutrition (OR, 2.65; 95% CI, 1.39-5.06), and the administration of anti-anaerobic agents (OR, 2.22; 95% CI, 1.03-4.79) were significantly more common among candidal CRBSIs. The (1,3)-β-D-glucan (BDG) test was positive among 94.6% (35/37) of candidal CRBSI patients and 9.4% (10/106) of non-candidal CRBSI cases. The administration of antifungal agents may be considered for patients with these risk factors, especially when the BDG test is positive.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Candida; Catheter-related bloodstream infection; Risk factor

Mesh:

Substances:

Year:  2014        PMID: 25266673     DOI: 10.1016/j.diagmicrobio.2014.08.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts.

Authors:  Andrzej Kozik; Justyna Karkowska-Kuleta; Dorota Zajac; Oliwia Bochenska; Sylwia Kedracka-Krok; Urszula Jankowska; Maria Rapala-Kozik
Journal:  BMC Microbiol       Date:  2015-10-05       Impact factor: 3.605

Review 2.  Practical approach to the management of catheter-related bloodstream infection.

Authors:  M L Cantón-Bulnes; J Garnacho-Montero
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

3.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.